New Products Launched At NACDS 2007
This article was originally published in The Tan Sheet
Executive Summary
Matrixx adds syrup, vapor to cold/flu relief: The Zicam cold and sinus product line will be extended with day- and night-time cold and flu syrups and a vapor-action tablet, Matrixx Initiatives announces at the National Association of Chain Drug Store's Marketplace trade show in Boston June 23-26. The syrup products in 8 oz. containers and the Zicam RapidMelts acetaminophen 325 mg and phenylephrine 5 mg tablets will retail at $6.99 each and will be available in stores in August, the Phoenix-based firm says. Matrixx adds the syrup products with a novel delivery system - marketed with the tag line "The Taste You Choose, virtually tasteless when added to any beverage" - to a line that already includes uniquely packaged disposable medicated dosing spoons designed to mix into hot or cold beverages (1"The Tan Sheet" June 13, 2005, p. 6). The day-time formulation contains acetaminophen 325 mg, dextromethorphan 10 mg and guaifenesin 200 mg; the night-time product contains 325 mg acetaminophen, dextromethorphan 10 mg and doxylamine succinate 6.25 mg...
You may also be interested in...
NACDS Marketplace In Brief
Bayer Rapid Headache Relief: TV spot supporting the launch of Bayer Rapid Headache Relief claims the product "releases medicine" five times faster than Tylenol Gels. The spot broke on national network and cable channels May 31. The product, which contains 500 mg aspirin/65 mg caffeine, was featured by Bayer at the National Association of Chain Drug Stores Marketplace in New Orleans June 5-7. A 50-count package retails for $5.25. The TV spot opens with a mother driving her children to soccer practice as an announcer says, "The number one cause of headaches: everyday life. Want fast relief? Introducing new Bayer Rapid Headache Relief." A message superimposed over an image of the Bayer and Tylenol Gel capsules dissolving notes the elapsed release time is 27 seconds for Bayer's product and 133 seconds for Tylenol...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands